Top Back to top

Impact of pre-existing invasive aspergillosis on allogeneic hematopoietic stem cell transplantation for treatment of acute leukaemia and myelodysplastic syndrome

Study number:
Type of transplant:
Short title:
IPAT study
Study status:
Deadline for data collection:
Study design:
Prospective study. Study recruitment is expected to start by May 1st, 2016. It is expected that
Primary objective:
to determine if pre-existing IA influences non-relapse mortality after allo-HSCT
Key inclusion criteria:
first allo in patients with AL or MDS
Principal investigator:
Olaf Penack
Principal investigator email:
Study coordinator email:

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to